190 related articles for article (PubMed ID: 31655274)
1. Machine learning and bioinformatics models to identify gene expression patterns of ovarian cancer associated with disease progression and mortality.
Hossain MA; Saiful Islam SM; Quinn JMW; Huq F; Moni MA
J Biomed Inform; 2019 Dec; 100():103313. PubMed ID: 31655274
[TBL] [Abstract][Full Text] [Related]
2. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
3. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
4. Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis.
Zou J; Li Y; Liao N; Liu J; Zhang Q; Luo M; Xiao J; Chen Y; Wang M; Chen K; Zeng J; Mo Z
J Ovarian Res; 2022 Feb; 15(1):30. PubMed ID: 35227296
[TBL] [Abstract][Full Text] [Related]
5. Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancer.
Gao Y; Liu X; Li T; Wei L; Yang A; Lu Y; Zhang J; Li L; Wang S; Yin F
Oncol Rep; 2017 May; 37(5):3084-3092. PubMed ID: 28350120
[TBL] [Abstract][Full Text] [Related]
6. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
7. RAD51AP1 promotes progression of ovarian cancer via TGF-β/Smad signalling pathway.
Zhao H; Gao Y; Chen Q; Li J; Ren M; Zhao X; Yue W
J Cell Mol Med; 2021 Feb; 25(4):1927-1938. PubMed ID: 33314567
[TBL] [Abstract][Full Text] [Related]
8. Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes.
Barnes BM; Nelson L; Tighe A; Burghel GJ; Lin IH; Desai S; McGrail JC; Morgan RD; Taylor SS
Genome Med; 2021 Sep; 13(1):140. PubMed ID: 34470661
[TBL] [Abstract][Full Text] [Related]
9. Establishment and validation of an RNA binding protein-associated prognostic model for ovarian cancer.
He C; Huang F; Zhang K; Wei J; Hu K; Liang M
J Ovarian Res; 2021 Feb; 14(1):27. PubMed ID: 33550985
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a SVM classifier to predict recurrence of ovarian cancer.
Zhou J; Li L; Wang L; Li X; Xing H; Cheng L
Mol Med Rep; 2018 Oct; 18(4):3589-3598. PubMed ID: 30106117
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of ALDH5A1 predicts prognosis in patients with ovarian cancer.
Tian X; Han Y; Yu L; Luo B; Hu Z; Li X; Yang Z; Wang X; Huang W; Wang H; Zhang Q; Ma D
Cancer Biol Ther; 2017 Apr; 18(4):245-251. PubMed ID: 28346042
[TBL] [Abstract][Full Text] [Related]
12. Association of ABC gene profiles with time to progression and resistance in ovarian cancer revealed by bioinformatics analyses.
Seborova K; Vaclavikova R; Soucek P; Elsnerova K; Bartakova A; Cernaj P; Bouda J; Rob L; Hruda M; Dvorak P
Cancer Med; 2019 Feb; 8(2):606-616. PubMed ID: 30672151
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analysis to screen the key prognostic genes in ovarian cancer.
Li L; Cai S; Liu S; Feng H; Zhang J
J Ovarian Res; 2017 Apr; 10(1):27. PubMed ID: 28407786
[TBL] [Abstract][Full Text] [Related]
14. Multifactor assessment of ovarian cancer reveals immunologically interpretable molecular subtypes with distinct prognoses.
Guo Y; Li S; Li C; Wang L; Ning W
Front Immunol; 2023; 14():1326018. PubMed ID: 38143770
[TBL] [Abstract][Full Text] [Related]
15. Identification of immune microenvironment subtypes that predicted the prognosis of patients with ovarian cancer.
Wang X; Li X; Wang X
J Cell Mol Med; 2021 Apr; 25(8):4053-4061. PubMed ID: 33675171
[TBL] [Abstract][Full Text] [Related]
16. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis.
Feng H; Gu ZY; Li Q; Liu QH; Yang XY; Zhang JJ
J Ovarian Res; 2019 Apr; 12(1):35. PubMed ID: 31010415
[TBL] [Abstract][Full Text] [Related]
17. Glycosylation-Related Genes Predict the Prognosis and Immune Fraction of Ovarian Cancer Patients Based on Weighted Gene Coexpression Network Analysis (WGCNA) and Machine Learning.
Zhao C; Xiong K; Zhao F; Adam A; Li X
Oxid Med Cell Longev; 2022; 2022():3665617. PubMed ID: 35281472
[TBL] [Abstract][Full Text] [Related]
18. Profiling and bioinformatics analyses reveal differential circular RNA expression in ovarian cancer.
Wang J; Wu A; Yang B; Zhu X; Teng Y; Ai Z
Gene; 2020 Jan; 724():144150. PubMed ID: 31589961
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide DNA copy number profiling and bioinformatics analysis of ovarian cancer reveals key genes and pathways associated with distinct invasive/migratory capabilities.
Liu G; Ruan G; Huang M; Chen L; Sun P
Aging (Albany NY); 2020 Jan; 12(1):178-192. PubMed ID: 31895688
[TBL] [Abstract][Full Text] [Related]
20. A random forest classifier predicts recurrence risk in patients with ovarian cancer.
Cheng L; Li L; Wang L; Li X; Xing H; Zhou J
Mol Med Rep; 2018 Sep; 18(3):3289-3297. PubMed ID: 30066910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
